Hirokazu Nagawa

Hirokazu Nagawa

Auto-generated profile, based on publicly available information

Hirokazu Nagawa

Department of Surgery, Division of Surgical Oncology, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2011 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JKJoji Kitayama
Joji Kitayama
KYKoji Yasuda
Koji Yasuda
KKKazushige Kawai
Kazushige Kawai
ESEiji Sunami
Eiji Sunami
HNHirokazu Nagawa
Hirokazu Nagawa
Although preoperative radiotherapy (RT) is widely used as the initial treatment for locally advanced rectal cancer (RC) in the neoadjuvant setting, factors determining clinical response have not been adequately defined. In order to find other factors possibly related with radiosensitivity, we evaluated the relationships between circulating blood cell counts and RT effects.